140 related articles for article (PubMed ID: 17652964)
1. Peroxisome proliferator-activated receptor-alpha deficiency protects aged mice from insulin resistance induced by high-fat diet.
Cha DR; Han JY; Su DM; Zhang Y; Fan X; Breyer MD; Guan Y
Am J Nephrol; 2007; 27(5):479-82. PubMed ID: 17652964
[TBL] [Abstract][Full Text] [Related]
2. Effect of heterozygous PPARgamma deficiency and TZD treatment on insulin resistance associated with age and high-fat feeding.
Miles PD; Barak Y; Evans RM; Olefsky JM
Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E618-26. PubMed ID: 12556354
[TBL] [Abstract][Full Text] [Related]
3. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity.
Matsuzawa-Nagata N; Takamura T; Ando H; Nakamura S; Kurita S; Misu H; Ota T; Yokoyama M; Honda M; Miyamoto K; Kaneko S
Metabolism; 2008 Aug; 57(8):1071-7. PubMed ID: 18640384
[TBL] [Abstract][Full Text] [Related]
4. Catalpic acid decreases abdominal fat deposition, improves glucose homeostasis and upregulates PPAR alpha expression in adipose tissue.
Hontecillas R; Diguardo M; Duran E; Orpi M; Bassaganya-Riera J
Clin Nutr; 2008 Oct; 27(5):764-72. PubMed ID: 18778878
[TBL] [Abstract][Full Text] [Related]
5. Diminished diet-induced hyperglycemia and dyslipidemia and enhanced expression of PPARalpha and FGF21 in mice with hepatic ablation of brain-derived neurotropic factor.
Teillon S; Calderon GA; Rios M
J Endocrinol; 2010 Apr; 205(1):37-47. PubMed ID: 20097691
[TBL] [Abstract][Full Text] [Related]
6. Haploinsufficiency of the retinoblastoma protein gene reduces diet-induced obesity, insulin resistance, and hepatosteatosis in mice.
Mercader J; Ribot J; Murano I; Feddersen S; Cinti S; Madsen L; Kristiansen K; Bonet ML; Palou A
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E184-93. PubMed ID: 19417128
[TBL] [Abstract][Full Text] [Related]
7. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet.
Fernandes-Santos C; Carneiro RE; de Souza Mendonca L; Aguila MB; Mandarim-de-Lacerda CA
Nutrition; 2009; 25(7-8):818-27. PubMed ID: 19268533
[TBL] [Abstract][Full Text] [Related]
8. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K
Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of peroxisomal proliferator activated receptors alpha and delta in skeletal muscle in response to changes in diet and exercise.
Kannisto K; Chibalin A; Glinghammar B; Zierath JR; Hamsten A; Ehrenborg E
Int J Mol Med; 2006 Jan; 17(1):45-52. PubMed ID: 16328010
[TBL] [Abstract][Full Text] [Related]
10. Phenotype of peroxisome proliferator-activated receptor-alpha(PPARalpha)deficient mice on mixed background fed high fat diet.
Kim BH; Won YS; Kim EY; Yoon M; Nam KT; Oh GT; Kim DY
J Vet Sci; 2003 Dec; 4(3):239-44. PubMed ID: 14685029
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-alpha deficiency does not alter insulin sensitivity in mice maintained on regular or high-fat diet: hyperinsulinemic-euglycemic clamp studies.
Haluzik M; Gavrilova O; LeRoith D
Endocrinology; 2004 Apr; 145(4):1662-7. PubMed ID: 14670996
[TBL] [Abstract][Full Text] [Related]
12. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
Cong WN; Tao RY; Tian JY; Liu GT; Ye F
Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
[TBL] [Abstract][Full Text] [Related]
13. Gender-dependent effect of Gpbar1 genetic deletion on the metabolic profiles of diet-induced obese mice.
Vassileva G; Hu W; Hoos L; Tetzloff G; Yang S; Liu L; Kang L; Davis HR; Hedrick JA; Lan H; Kowalski T; Gustafson EL
J Endocrinol; 2010 Jun; 205(3):225-32. PubMed ID: 20354075
[TBL] [Abstract][Full Text] [Related]
14. A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes.
Finck BN; Bernal-Mizrachi C; Han DH; Coleman T; Sambandam N; LaRiviere LL; Holloszy JO; Semenkovich CF; Kelly DP
Cell Metab; 2005 Feb; 1(2):133-44. PubMed ID: 16054054
[TBL] [Abstract][Full Text] [Related]
15. Fetuin-null mice are protected against obesity and insulin resistance associated with aging.
Mathews ST; Rakhade S; Zhou X; Parker GC; Coscina DV; Grunberger G
Biochem Biophys Res Commun; 2006 Nov; 350(2):437-43. PubMed ID: 17011519
[TBL] [Abstract][Full Text] [Related]
16. Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist.
Chen X; Matthews J; Zhou L; Pelton P; Liang Y; Xu J; Yang M; Cryan E; Rybczynski P; Demarest K
Metabolism; 2008 Nov; 57(11):1516-25. PubMed ID: 18940388
[TBL] [Abstract][Full Text] [Related]
17. Fraxinus excelsior seed extract FraxiPure™ limits weight gains and hyperglycemia in high-fat diet-induced obese mice.
Ibarra A; Bai N; He K; Bily A; Cases J; Roller M; Sang S
Phytomedicine; 2011 Apr; 18(6):479-85. PubMed ID: 21036576
[TBL] [Abstract][Full Text] [Related]
18. Bitter gourd (Momordica charantia) improves insulin sensitivity by increasing skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat-fed rats.
Sridhar MG; Vinayagamoorthi R; Arul Suyambunathan V; Bobby Z; Selvaraj N
Br J Nutr; 2008 Apr; 99(4):806-12. PubMed ID: 17942003
[TBL] [Abstract][Full Text] [Related]
19. FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver.
Huang X; Yang C; Luo Y; Jin C; Wang F; McKeehan WL
Diabetes; 2007 Oct; 56(10):2501-10. PubMed ID: 17664243
[TBL] [Abstract][Full Text] [Related]
20. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
